BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32907555)

  • 1. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
    Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
    BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Thrombomodulin in Disseminated Intravascular Coagulation Associated with Stage IV Solid Tumors: A Nationwide Observational Study in Japan.
    Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2021 Jan; 121(1):36-45. PubMed ID: 32906154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2014 Sep; 12(9):1470-9. PubMed ID: 24943516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study.
    Tagami T; Matsui H; Horiguchi H; Fushimi K; Yasunaga H
    J Thromb Haemost; 2015 Jan; 13(1):31-40. PubMed ID: 25393713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with Antithrombin or Thrombomodulin and Mortality from Heatstroke-Induced Disseminated Intravascular Coagulation: A Nationwide Observational Study.
    Ohbe H; Isogai S; Jo T; Matsui H; Fushimi K; Yasunaga H
    Semin Thromb Hemost; 2019 Nov; 45(8):760-766. PubMed ID: 31627216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study.
    Umemura Y; Yamakawa K; Hayakawa M; Kudo D; Fujimi S
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):734-740. PubMed ID: 29471674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan.
    Yamakawa K; Umemura Y; Hayakawa M; Kudo D; Sanui M; Takahashi H; Yoshikawa Y; Hamasaki T; Fujimi S;
    Crit Care; 2016 Jul; 20(1):229. PubMed ID: 27472991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study.
    Hayakawa M; Kudo D; Saito S; Uchino S; Yamakawa K; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Shock; 2016 Dec; 46(6):623-631. PubMed ID: 27548460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Human Soluble Thrombomodulin Contributes to a Reduction In-Hospital Mortality of Acute Cholangitis with Disseminated Intravascular Coagulation: A Propensity Score Analyses of a Japanese Nationwide Database.
    Tarasawa K; Fujimori K; Fushimi K
    Tohoku J Exp Med; 2020 Sep; 252(1):53-61. PubMed ID: 32879147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation.
    Umegaki T; Kunisawa S; Nishimoto K; Kamibayashi T; Imanaka Y
    Sci Rep; 2020 Mar; 10(1):4874. PubMed ID: 32184456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan.
    Iwasaki Y; Ohbe H; Shigemi D; Fushimi K; Yasunaga H
    BJOG; 2022 Apr; 129(5):805-811. PubMed ID: 34545675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
    Nagafuchi H; Eguchi Y; Ikeda T
    Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Murao A; Kato T; Yamane T; Honda G; Eguchi Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation.
    Yasuda N; Goto K; Ohchi Y; Abe T; Koga H; Kitano T
    J Crit Care; 2016 Dec; 36():29-34. PubMed ID: 27546744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation Therapy Using rh-Thrombomodulin and/or Antithrombin III Agent is Associated With Reduction in in-Hospital Mortality in Septic Disseminated Intravascular Coagulation: A Nationwide Registry Study.
    Tanaka K; Takeba J; Matsumoto H; Ohshita M; Annen S; Moriyama N; Nakabayashi Y; Aibiki M
    Shock; 2019 Jun; 51(6):713-717. PubMed ID: 31090683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.